The utilization of thymoquinone in the treatment of human osteosarcoma is also suggested by Roepke and collaborators [62], who showed that it induced p53-independent apoptosis, which is important because loss of p53 function is frequently observed in osteosarcoma patients. The gene discussed is TP53; the disease is osteosarcoma.